Various neoplasms, including thymus-related lesions, lymphomas and germ cell tumors, involve the anterior mediastinum. Thymic epithelial tumors are the most common type of thymus-related lesions. Thymic epithelial tumors are classified in two major groups, thymomas and thymic carcinomas, in the latest World Health Organization (WHO) classification (2004). There are various pathological types of thymic epithelial tumors, and the clinical features and prognosis associated with each tumor depend on the pathological type. Furthermore, the WHO histological classification and Masaoka staging, a surgical staging system based on the presence of invasion in the surrounding organs, closely correlate with prognosis. To differentiate and predict the histology and initial staging of tumors, conducting less invasive imaging evaluations prior to administering any invasive procedures or treatments is important. CT and MRI are useful for evaluating the morphological appearance of tumors and the presence of invasion in surrounding fat tissues or structures such as the pleura, lungs or vessels. However, some findings are overlapping, which thus makes it difficult to diagnose histological subtypes correctly. On the other hand, fluoro-deoxy-glucose positron emission tomography (FDG-PET) can provide useful metabolic information regarding thymic lesions.
INTRODUCTION
Various neoplasms, including thymus-related lesions, lymphomas and germ cell tumors, involve the anterior mediastinum. Thymic epithelial tumors are the most common type of thymus-related lesions. Thymic epithelial tumors are classified in two major groups, thymomas and thymic carcinomas, in the latest World Health Organization (WHO) classification (2004) . There are various pathological types of thymic epithelial tumors, and the clinical features and prognosis associated with each tumor depend on the pathological type. Furthermore, the WHO histological classification and Masaoka staging, a surgical staging system based on the presence of invasion in the surrounding organs, closely correlate with prognosis. To differentiate and predict the histology and initial staging of tumors, conducting less invasive imaging evaluations prior to administering any invasive procedures or treatments is important. CT and MRI are useful for evaluating the morphological appearance of tumors and the presence of invasion in surrounding fat tissues or structures such as the pleura, lungs or vessels. However, some findings are overlapping, which thus makes it difficult to diagnose histological subtypes correctly. On the other hand, fluoro-deoxy-glucose positron emission tomography (FDG-PET) can provide useful metabolic information regarding thymic lesions.
In this article, the available literature on the utility of FDG-PET in the diagnosis of thymic epithelial tumors is reviewed and the results of an investigation conducted in our institute are reported.
THYMIC EPITHELIAL TUMORS
Histological classification (Table 1) The World Health Organization (WHO) published the histological classification in 1999. In this version, thymomas were divided into five subtypes and thymic carcinomas were classified as type C. The WHO classification was renewed in 2004 and this version of the classification is widely used today. In the 2004 classification, rare subtypes were added to traditional types, type C was removed and thymic carcinomas were classified in various subtypes, including neuroendocrine epithelial tumors. Thymomas were divided into type A and type B according to the shape of the tumor cells and nuclei. Type B was also subdivided in three subtypes, B1, B2 and B3, according to the number of lymphocytes and the atypia of the tumor cells. Type B1 is lymphocytedominant and type B3 is epithelial componentdominant. The grade of malignancy increases with the progression of each subtype : A, AB, B1, B2, B3. Thymic carcinomas were defined as all malignant non-organotypic epithelial neoplasms except germ cell tumors. Squamous cell carcinomas are the most common type of thymic carcinomas. Thymic epithelial tumors are divided into three subgroups based on prognosis and WHO histological classification : low-risk (LR), including types A, AB and B1 ; high-risk (HR), including types B2 and B3 ; and thymic carcinomas (CA).
Clinical staging
Masaoka staging is widely used to assess thymomas (Table 2) and is closely correlated with the prognosis. Masaoka staging is based on the presence of invasion in the capsule or surrounding organs, the existence of pleural or pericardial dissemination and the presence of lymphogenous or hematogenous metastasis. WHO TNM classification for malignant thymic epithelial tumors was published in 2009 (Table 3) .
FDG-PET

Review of previous reports
The author searched the PubMed database inserting the following key words : "thymus," "epithelial," "tumor," "PET" and "FDG" and found seven studies evaluating the utility of FDG-PET in the diagnosis of thymic epithelial tumors. The author also added the results of an investigation conducted in Tokushima University Hospital to this article. A summary is shown in Table 4 (1-7). Three of the seven articles grouped thymic epithelial tumors into three subgroups (low-risk, high-risk and thymic carcinomas) (1, 2, 4), three articles classified thymic epithelial tumors into two subgroups (lowrisk and high-risk (types B2, B3 and thymic carcinomas)) (3, 5, 7) and one article grouped thymic epithelial tumors into thymoma and thymic carcinoma groups (6) . Two articles used the T/M ratio of maximum standardized uptake value (SUVmax) to evaluate the degree of FDG uptake (2, 4) . One article reported the use of dual time-point, early and delayed scans (3) . Two articles mentioned the biologic correlations between thymic epithelial tumors and glucose transporters (Glut), hexokinase, hypoxia, angiogenesis and cell cycle regulators (4, 5). Sung et al. classified 33 cases of thymic epithelial tumors into low-risk (types A, AB and B1), highrisk (types B2 and B3) thymoma, and thymic carcinoma, and investigated the FDG-PET/CT as well as enhanced CT. The SUVmax of the low-risk and high-risk groups was statistically significantly lower than that of thymic carcinoma. FDG uptake pattern and mediastinal fat invasion using enhanced CT was useful for differentiating subgroups ; whereby, it was determined that lymph node metastasis that could not be indicated using enhanced CT was indicated using PET/CT in 2 of 33 patients, and it was reported that PET/CT was useful for differentiating subgroups as well as the staging of thymic epithelial tumors (1). Endo et al. divided 36 cases of thymic epithelial tumors into 3 groups (low-risk, highrisk and thymic carcinoma) in the same manner as Sung et al., and the SUVmax of the lesions with respect to the mediastinal SUVmax was investigated as a T/M ratio (ratio of the peak SUV of the tumor to the mean SUV of the mediastinum at the level of the aortic arch). As a result, it was reported that 3 groups may be differentiating using the T/M ratio, and that PET was useful in the evaluation of thymic epithelial tumors (2). Kaira et al. also evaluated thymic epithelial tumors in 49 patients using the T/M ratio, reporting that the T/M ratio was significantly high in relation to the grade of malignancy. In this paper, it is shown that the biologic mechanism of the FDG uptake to thymic epithelial tumors is related to glucose metabolism, hypoxia, angiogenesis 
INVESTIGATION IN TOKUSHIMA UNIVER-SITY HOSPITAL
Patients and methods
This retrospective study was approved by the institutional review board of Tokushima University Hospital. The research content was posted on the information board at the entrance to the Imaging Center of Tokushima University Hospital. Written informed consent for FDG-PET/CT examination and contrast enhanced CT was obtained from all patients.
Patient population
Thirty-five (17 males, 18 females ; age range 27 to 84 years, mean/SD : 61.6/14.3) patients with FDG-positive and pathologically confirmed thymic epithelial lesions who underwent FDG-PET/CT and enhanced CT or non-enhanced diagnostic CT prior to initial surgery, chemotherapy or radiation therapy were enrolled in this study.
FDG-PET/CT
All FDG-PET/CT examinations were performed before any treatments were administered. All patients were instructed to be fast for at least 6 hours before FDG injection. The FDG-PET/CT images were obtained one hour after the intravenous injection of 3.7 MBq/kg body weight of FDG. The patients' blood glucose levels were confirmed to be less than 150 mg/dl immediately prior to the administration of FDG. Images were obtained using a hybrid PET/CT scanner (Aquiduo, Toshiba, Japan) in 3-dimensional mode under free breathing. The first images were localized images taken from the top of the skull to the middle of the thigh followed by CT images obtained with a 16-slice multidetector CT system. Emission data were acquired in the caudo-cranial direction from the middle of the thigh to the top of the skull. Two minutes of acquisition time were used per bed position and most patients required eight bed positions. Image reconstruction was completed using an ordered subset expectation maximization (OSEM) algorithm (two iterations, 14 subsets). Attenuation-corrected emission data were obtained using filtered back projection CT data.
Chest CT
CT scans were performed primarily at Tokushima University Hospital (32 patients), with the exception of three patients. Isovoxel data were acquired using 16-slice multi-detector CT performed in our institution with 1 mm slice thickness and 2 ml/kg body weight of iodine contrast material. Thirty enhanced and five non-enhanced CT images were reviewed. Scanning protocol such as scanning time and the injection rate, dose and iodine concentration of the contrast material were varied according to patient condition, including patient body weight and renal function.
Image interpretation
Two observers (board certificated physicians of
The Journal of Medical Investigation Vol. 59 August 2012 diagnostic radiology/nuclear medicine/PET and diagnostic radiology/PET) reviewed the FDG-PET/ CT, enhanced and non-enhanced chest CT images. The chest CT, PET and CT portions of the PET/ CT images were analyzed for attenuation correction and anatomical recognition, and the fused PET/CT images obtained in the axial, transverse and coronal views were interpreted using Aquarias Net software (TeraRecon). The maximum standardized uptake value (SUVmax) of each lesion was measured to evaluate the degree of FDG uptake.
The observers were given notice that the lesions were FDG-positive thymic epithelial lesions ; however, they were blind to the following information : final pathology, staging, age, gender, clinical symptoms, laboratory data and indication for FDG-PET/ CT examination. On the FDG-PET images, the degree of FDG uptake and the presence of FDG-positive lymph nodes, dissemination, distant metastasis and other primary lesions were evaluated. On the CT images, the observers reviewed the size, contour, shape, contrast enhancement pattern and existence of cystic or necrotic portions, calcification, invasion of adjacent structures, dissemination, pleural effusion, pericardial effusion or lymphadenopathy of each lesion.
Statistical analysis
The difference between the SUVmax and size of each lesion were evaluated between subgroups using the Kruskal-Wallis test or t-test. A p value less than 0.05 was considered to be statistically significant.
RESULTS
A summary is shown in Table 5 and images of type A, type B2 and thymic carcinomas are shown in Figures 1-3. ( (a a) ) ( (b b) ) ( (c c) ) Fifteen patients showed symptoms of chest pain or discomfort and two patients had blepharoptosis. Twenty patients were incidentally found to have abnormal anterior mediastinal lesions on chest Xray or chest CT. Pathologically, LR lesions were found in 11 patients (type A : three patients, type AB : three patients and type B1 : five patients), HR lesions were found in 13 patients (type B1/2 : two patients, type B2 : seven patients, type B2/3 : two patients and type B3 : two patients) and CAs were found in 11 patients. Two patients in the LR group had lung adenocarcinomas, one patient in the HR group had a large-cell lung carcinoma and one CA patient had FDG-negative ground glass opacity on CT that was confirmed to be a bronchoalveolar cell carcinoma using video-assisted thoracic surgery. Ten of 11 LR patients (91%) were found to be in early Masaoka stages (I, II), whereas 10 of 11 CA patients (91%) were found to be in advanced stages (III, IV). Six of 11 (55%) CA patients were found to have metastasis at the initial diagnosis. The Masaoka stages of the HR lesions varied from early to advanced, with advanced stages dominating. Nine of 13 patients (70%) were diagnosed in stages III or IV.
The SUVmax values of the CA lesions were found to be higher than those of the LR and HR lesions (mean +/-SD : CA : 7.6 +/-3.7, LR : 3.7 +/-1.8 and HR : 4.0 +/-2.3). The differences between the values of the CA and LR lesions and the CA and HR lesions were statistically significant (p=0.007 and 0.008, respectively), while the difference between the values of the HR and LR lesions was not significant (p=0.99). The difference between the values of the thymoma (LR and HR) and thymic carcinoma lesions was statistically significant (p=0.000482). The LR lesions tended to be smaller and the CA lesions tended to be larger with a statistically significant difference (p=0.022). The LR lesions had round/oval shapes with smooth margins, while the CA lesions were lobulated with irregular margins. The HR lesions had various shapes and margins and tended to be lobulated with irregular margins. Degenerative changes and necrosis were found in all CA lesions and in six of 11 (55%) LR lesions and eight of 13 (62%) HR lesions. Calcification was detected in 31% of all lesions (11/35) . No calcification was detected in the LR lesions. The CA lesions showed heterogeneous contrast enhancement on CT, and the enhancement pattern varied in the LR and HR lesions. The levels of anti-acetylcholine receptor (anti-AchR) antibodies were analyzed in a limited number of patients. Two of 10 (20%) LR patients, one of nine (11%) HR patients and zero CA patients were found to have elevated values. One HR patient with an elevated anti-AchR level had symptoms of myasthenia gravis.
DISCUSSION
The prognoses of patients with thymic epithelial lesions are significantly correlated with two factors : histological classification and clinical staging. The WHO updated the histological classification to include five subtypes of thymomas and thymic carcinomas in 2004. It is reported that thymic epithelial tumors found that the 5-year survival rate was 100% in patients with type A tumors, 93% in patients with type AB tumors, 89% in patients with type B1 tumors, 82% in patients with type B2 tumors, 71% in patients with type B3 tumors and 48.0% in patients with thymic carcinomas (8) . Therefore, patients with low-risk thymomas have good prognoses, whereas the prognoses of patients with high-risk thymomas worsen with the progression from type B2 to type B3 lesions and patients with thymic carcinomas have poor prognoses. Masaoka's criteria is widely used to determine clinical staging. The criteria are based on the presence of invasion in adjacent mediastinal adipose tissue or surrounding organs, and Masaoka staging significantly correlates with prognosis. The 20-year survival rate is 89% in patients with stage I disease, 91% in patients with stage II disease, 49% in patients with stage III disease and 0% in patients with stage VIa or VIb disease. There is a significant divergence in prognosis between patients with early (stages I, II) and advanced stage (stages III, IV) disease. Therefore, predicting whether the histological grade is low-risk, high-risk or carcinoma and properly diagnosing the existence of invasion to surrounding organs such as the pericardium, great vessels or lungs are important before performing invasive procedures or administrating treatment. CT and MRI are reported to be useful in evaluating thymic epithelial lesions (9) (10) (11) (12) . On CT, thymomas appear as round or oval-shaped soft tissue masses with mild to moderate contrast enhancement. Degenerative changes or necrosis present as low density areas in the lesions. Calcification is detected by the presence of high density spots. Jeong reported that, on CT, lobulated contours were more often seen in high-risk thymomas and thymic carcinomas (9) . Sadohara reported that the presence of irregular contours, necrosis or cystic components, heterogeneous enhancement and lymphadenopathy are highly suggestive of thymic carcinomas (10) . In our study, the LR lesions tended to be smaller than the CA lesions with a statistically significant difference (p=0.005). The LR lesions were round/ oval-shaped with smooth margins, while the CA lesions were lobulated with irregular margins. The HR lesions had various shapes and margins and tended to be lobulated with irregular margins. Degenerative changes and necrosis were found in all CA lesions and in 50% of the LR lesions and seven of 11 (64%) of the HR lesions. Calcification was detected in 29% of all lesions (9/31). No calcification was detected in the LR lesions. The CA lesions showed heterogeneous contrast enhancement on CT, while the enhancement pattern varied in the LR and HR lesions. On MRI, thymomas show low intensity on T1-weighted images, similar to that of muscle, and relatively high intensity on T2-weighted images. T2-weighted images show necrosis as high intensity and internal septa as low intensity. T1-weighted images show various signal patterns in cystic regions ranging from low to high intensity, reflecting the protein content and the presence of hemorrhage. It is reported that MRI can differentiate low-risk thymomas from high-risk thymomas by depicting contours, capsules, septa and contrast enhancement patterns. With respect to depicting invasion outside of capsules, MRI is reported to be superior to CT. Pathologically proving invasion in surgical specimens is the most reliable method of determining the presence of invasion, as CT and MRI cannot detect microscopic invasion. In this study, we underdiagnosed one thymic carcinoma patient.
FDG-PET/CT is an advancing modality used to evaluate tumor activity, glucose metabolism and whole body morphology in a single session. It has become an important noninvasive diagnostic tool in the management of thymic lesions. FDG accumulates in tumor cells according to viability or pathological grading. Moreover, FDG accumulation is affected by various factors, such as glucose metabolism, hypoxia, angiogenesis. FDG accumulation of low-risk thymoma is low, and FDG accumulation of thymic carcinoma is high. High-risk thymoma exhibits various degrees of accumulation and a definite conclusion has not yet been reached ; however, overall, the higher the histological grade, the higher the FDG accumulation becomes, suggesting that this is correlated to staging. FDG-PET may indicate lymph node metastasis and distant metastasis, which are sometimes difficult to detect using other modalities. When lymph node metastasis and/or distant metastasis are suspected in addition to thymic lesions, it is not practical to histologically confirm the metastatic lesions, and in such cases, FDG-PET/ CT, which allows for searching of the entire body at once, is useful.
In summary, FDG-PET/CT is effective for estimating histopathological malignancy and staging in the diagnosis of thymic epithelial tumors and may be an important imaging test with high relevance to the prognosis of a patient.
Some portions of the data were presented at the 58th annual meeting of the Society of Nuclear Medicine in 2011. The author greatly thanks "the Nuclear Medicine Team" of Tokushima University Hospital.
